ZNHIT3 inhibitors are a specialized class of chemical compounds that target and inhibit the activity of the ZNHIT3 protein. ZNHIT3, or Zinc Finger HIT-Type Containing 3, is a zinc-binding protein involved in various cellular processes, including chromatin remodeling, gene expression, and protein-protein interactions. The inhibition of ZNHIT3 can influence the assembly and regulation of macromolecular complexes, particularly those involved in histone modification. This protein's zinc finger motif is critical for its ability to bind to DNA and other proteins, acting as a mediator in epigenetic regulation. ZNHIT3 inhibitors, therefore, are designed to disrupt this binding capacity, leading to alterations in the dynamic structure of chromatin and, ultimately, influencing the transcriptional activity of certain genes.
On a molecular level, ZNHIT3 inhibitors are structured to bind specifically to the active site or the zinc finger domain of the protein. By preventing proper zinc ion coordination or blocking key interaction sites, these inhibitors can induce conformational changes that destabilize the protein's function. The chemical composition of ZNHIT3 inhibitors is often characterized by high affinity for zinc-binding motifs and precise targeting of the protein's interaction networks. These inhibitors are valuable tools in molecular biology research as they enable scientists to study the functional role of ZNHIT3 in chromatin regulation, cell cycle control, and its broader role in the maintenance of genomic stability. Through the application of ZNHIT3 inhibitors, researchers can better understand the underlying mechanisms governing gene expression and protein dynamics in various biological systems.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR pathway, which can regulate the assembly of multi-protein complexes that ZNHIT3 may be a part of. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that can alter chromatin structure, potentially affecting ZNHIT3 binding affinity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that can change gene expression, possibly altering ZNHIT3 function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can increase cellular protein levels, including proteins that interact with ZNHIT3. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Lysosomotropic agent that can alter autophagic processes, indirectly affecting ZNHIT3-related pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that can affect MAPK/ERK pathway, potentially influencing ZNHIT3 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can impact AKT signaling, potentially modulating ZNHIT3's role in cellular processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that can interfere with stress response pathways, possibly affecting ZNHIT3's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can affect AP-1 transcription factor activity, potentially influencing ZNHIT3. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that can perturb protein degradation pathways, indirectly impacting ZNHIT3. | ||||||